Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…y were screened for the presence of pruritus via the worst-itch numerical rating scale (WI-NRS, 3-month recall) between January 2021 and January 2022.…
… followed up on treatment compliance using follow-up forms. The pneumonia treatment coverage will be assessed using baseline, midline and…
…heast Asian, Black and South Asian compared with White persons. Diabetes prevalence was highest in immigrants from South Asia, Southeast…
…ated with a small reduction in pain intensity for patients with fibromyalgia.…
… arrhythmia in patients with ischaemic heart disease. New-onset atrial fibrillation after coronary revascularisation is associated with adverse car…
…Background Previous literature suggested that rheumatoid arthritis (RA) might be a risk factor for nontuberculous mycobacteria pul…
…ility of using existing devices for salvage EVT of intracranial restenosis and compare the two salvage procedural approaches.Methods Conse…
…results through Week 48, during which all participants received Fenebrutinib 200 mg BID.Results 99 participants enrolled in the OLE; and 96 …
…e-modifying therapies (DMTs) in early Alzheimer’s disease (AD). Lecanemab and donanemab have received FDA approval and could be introduce…
…tors and modifiable lifestyle factors have been associated with dementia risk in observational studies. Exercise is a modifiable lifesty…
…ed elsewhere. More NHNN patients on active treatment (n=87) use Risdiplam (77%) than Nusinersen (23%). Notably, 95% of patients adhered t…
…ve searches will be conducted from inception to May 2025 across PubMed (NCBI), MEDLINE (Ovid), Web of Science, Cochrane Library, Scopu…